Georg Gelbenegger Selected Research

Ad26COVS1

8/2021

Rhabdomyolysis Following Ad26.COV2.S COVID-19 Vaccination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Georg Gelbenegger Research Topics

Disease

5	Thrombosis (Thrombus) 04/2022 - 01/2020
4	Stroke (Strokes) 01/2021 - 11/2017
4	Hemorrhage 01/2021 - 11/2019
3	Myocardial Infarction 01/2021 - 11/2019
2	ST Elevation Myocardial Infarction 04/2022 - 02/2020
2	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2022 - 01/2020
2	COVID-19 01/2022 - 08/2021
2	Critical Illness (Critically Ill) 01/2020 - 07/2017
2	Endotoxemia 01/2019 - 07/2018
1	Type 2 von Willebrand Disease 01/2022
1	Myalgia 08/2021
1	Muscle Weakness 08/2021
1	Rhabdomyolysis 08/2021
1	Diabetes Mellitus 01/2021
1	Heart Failure 01/2021
1	Proteinuria 01/2021
1	Acute Coronary Syndrome 01/2021
1	Thrombotic Microangiopathies 10/2020
1	Hemophilia A (Haemophilia) 10/2020
1	Out-of-Hospital Cardiac Arrest 02/2020
1	Hypothermia 02/2020
1	Heart Arrest (Cardiac Arrest) 02/2020
1	Hemolysis 01/2020
1	Disseminated Intravascular Coagulation 01/2020
1	Ischemic Stroke 11/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2019
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2019
1	Inflammation (Inflammations) 07/2018
1	Necrosis 07/2018
1	Dehydration (Water Stress) 11/2017
1	Type 2 Diabetes Mellitus (MODY) 11/2017

Drug/Important Bio-Agent (IBA)

3	von Willebrand FactorIBA 01/2022 - 01/2020
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 07/2017
3	TicagrelorIBA 01/2021 - 02/2020
3	omega-Chloroacetophenone (Mace)IBA 01/2021 - 11/2019
2	sutimlimabIBA 01/2022 - 01/2020
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2021 - 01/2021
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 11/2017
2	C-Reactive ProteinIBA 01/2019 - 07/2018
1	AnticoagulantsIBA 01/2022
1	Platelet Membrane GlycoproteinsIBA 01/2022
1	VaccinesIBA 08/2021
1	Ad26COVS1IBA 08/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 08/2021
1	clazakizumabIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Prasugrel Hydrochloride FDA Link 01/2021
1	SodiumIBA 01/2021
1	SymportersIBA 01/2021
1	Prothrombin (Factor II)IBA 10/2020
1	emicizumabIBA 10/2020
1	Factor VIII (Coagulation Factor VIII)IBA 10/2020
1	cangrelorIBA 02/2020
1	Complement C1s (C1 Esterase)IBA 01/2020
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2020
1	Dacarbazine (DIC)FDA LinkGeneric 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	defibrotideIBA 01/2019
1	ThrombomodulinIBA 07/2018
1	P-SelectinIBA 07/2018
1	Interleukin-6 (Interleukin 6)IBA 07/2018
1	vorapaxarIBA 07/2018
1	Proteinase-Activated ReceptorsIBA 07/2018
1	empagliflozinIBA 11/2017
1	Sodium-Glucose Transport ProteinsIBA 11/2017
1	Pharmaceutical PreparationsIBA 11/2017
1	Arachidonic Acid (Vitamin F)IBA 07/2017

Therapy/Procedure

3	Stents 04/2022 - 02/2020
2	Therapeutics 11/2017 - 07/2017
1	Subcutaneous Injections 08/2021
1	Stem Cell Transplantation 01/2019
1	Nursing Care 11/2017